CN1720997A - The preparation method of antineoplastic nanometer heat sensitive target medicine carrier - Google Patents
The preparation method of antineoplastic nanometer heat sensitive target medicine carrier Download PDFInfo
- Publication number
- CN1720997A CN1720997A CNA2005100405719A CN200510040571A CN1720997A CN 1720997 A CN1720997 A CN 1720997A CN A2005100405719 A CNA2005100405719 A CN A2005100405719A CN 200510040571 A CN200510040571 A CN 200510040571A CN 1720997 A CN1720997 A CN 1720997A
- Authority
- CN
- China
- Prior art keywords
- aam
- nipaam
- preparation
- poly
- copolymer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The present invention relates to a kind of preparation method of the antineoplastic nanometer heat sensitive target medicine carrier of using in conjunction with the chemotherapy thermotherapy.The present invention is a monomer polymerization with N-N-isopropylacrylamide (NIPAAm) and acrylamide (Aam), form copolymer poly (NIPAAm-co-Aam), make hydrophilic segment, again with copolymer poly (NIPAAm-co-Aam) and D, the L-lactide is by getting poly (NIPAAm-co-Aam) copolymer and poly-D behind the ring-opening polymerization, the block copolymer of L-lactide, make block copolymer, again block copolymer is dissolved among the DMAc, spontaneous formation micellar structure makes pharmaceutical carrier in water.The drug targeting carrier of the present invention's preparation can not be eliminated in human body in long-term circulation, only just discharge chemotherapeutics at thermotherapy tumor tissues place, chemotherapeutics has reduced the infringement of chemotherapeutics to human normal tissue cell in the tumor tissues not high defective that distributes when having solved existing chemotherapy combined with hyperthermia application of treatment tumor.
Description
Technical field
The present invention relates to a kind of pharmaceutical carrier, particularly a kind of preparation method of the antineoplastic nanometer heat sensitive target medicine carrier of using in conjunction with the chemotherapy thermotherapy.
Background technology
Present stage, the traditional method of treatment tumor is a chemotherapy, and its toxic and side effects is restricted the application of chemotherapy.If the reduction dosage can alleviate toxic and side effects, but can reduce the control action to tumor, this is a contradiction.
Thermotherapy also is a treatment tumor method commonly used, promptly makes tumor tissues reach 40-43 ℃ by heating, is to cause tumor cell tissue's growth retardation and dead a kind of Therapeutic Method.Early stage thermotherapy just is applied to the treatment of superficial tumor, and the back is owing to the application of deep radio frequency and whole-body hyperthermia equipment, and thermotherapy is used widely.But thermotherapy only is an aspect, usually is a kind of cooperation to the other treatment method, the important Drug therapy that still needs.
At present, be combined in the clinical practice chemotherapy and thermotherapy commonplace.For specific chemotherapeutics, thermotherapy can promote that chemotherapeutics enters tumor cell, promote chemotherapeutics induced tumor apoptosis, thermotherapy can reach higher temperature in the tumor tissues centre, make its easier induced tumor histiocyte apoptosis under sour environment, tumor periphery position blood peripheral position chemotherapy is just had advantage, so thermochemotherapy is in conjunction with covering the whole of tumor focus for more.Known can bring into play synergistic chemotherapeutics with thermotherapy platinum class, topoisomerase II inhibitor, topoisomerase I inhibitor are arranged, strongly select, paclitaxel, vincaleucoblastine, mitomycin etc.Adopt the bonded method treatment of this thermotherapy and chemotherapy gastric cancer peritoneal metastasis, cancer of pancreas, hepatocarcinoma, colorectal cancer etc. that certain curative effect is all arranged.More single chemotherapy of the bonded mode of this chemotherapy and thermotherapy or thermotherapy are much superior.But, in chemotherapy with during thermotherapy combines, how reducing chemotherapeutics still is the thing of part difficulty to human normal cell's infringement, simultaneously the partial thermotherapy of tumor tissues being cooperated with chemotherapeutics to produce better therapeutic, is that targeting discharges medicine and just becomes key point so how chemotherapeutics arrives that tumor tissues discharges.
Before the present invention, existing researcher is a feedstock production thermal sensitivity carrier with the N-N-isopropylacrylamide, but the carrier lower critical solution temperature of its structure (being called for short LCST) is lower than 37 ℃, the temperature-sensitive polymer undergoes phase transition after entering human body (blood heat is 37 ℃) like this, can't reach the purpose of targeted release.In addition, also the someone has made up N-N-isopropylacrylamide analog copolymer and has reached the artificial elastin-like polypeptides vector that makes by gene transfection, LCST reaches necessary requirement (about 42 ℃), this carrier combines with amycin, obtained targeting effect preferably, promptly under the thermotherapy method cooperates, chemotherapeutics is transported to the tumor tissue cell place by carrier to be discharged again, make its performance therapeutic effect, and guarantee in course of conveying, not reach tumor tissue cell's when place chemotherapeutics and do not discharge, thereby significantly reduce the toxic and side effects of chemotherapeutics.But, the constructed carrier of this method need combine with amycin by chemical bond, not only synthetic own just relatively more difficult, be difficult to promote the use of other chemotherapeutics, and very easily change the activity of chemotherapeutics itself by the mode of chemical bond combination, influence the effect of chemotherapeutics control tumor treatment, this is fatal defective.
Summary of the invention
Purpose of the present invention just is to overcome above-mentioned defective, the preparation method of research, a kind of antineoplastic nanometer heat sensitive target medicine carrier of invention.
Technical scheme of the present invention is: the preparation method of antineoplastic nanometer heat sensitive target medicine carrier, and its major technique is characterised in that following steps:
(1) preparation of hydrophilic segment:
With N-N-isopropylacrylamide (NIPAAm) and acrylamide (Aam) is monomer polymerization, by free radicals copolymerization reaction, forms copolymer poly (NIPAAm-co-Aam), and its reaction equation is
(2) preparation of block copolymer:
With copolymer poly (NIPAAm-co-Aam) and D, the L-lactide passes through to get poly (NIPAAm-co-Aam) copolymer and poly-D behind the ring-opening polymerization, the block copolymer of L-lactide, and its reaction equation is
(3) preparation of carrier:
The block copolymer of some is dissolved among the DMAc, and solution is positioned in the bag filter and dialyses, and block copolymer is spontaneous formation micellar structure in water, and solution lyophilization in the bag filter is promptly got carrier, 4 ℃ of preservations.
Advantage of the present invention and effect are to prepare a kind of in chemotherapy; nano target medicine carrier during combined with hyperthermia is used; Bao Zaiwei non-bonding combination to medicine; hydrophilic segment is wherein wrapped up hydrophobic fragment kernel as shell and is formed Amphiphilic Block Copolymer Micelles; because the lower critical solution temperature (LCST) of hydrophilic site temperature-sensitive polymer (polymer) is higher than 37 ℃; be lower than after the thermotherapy 42 ℃ of tumor tissues temperature again; therefore hydrophilic segment is under blood heat's 37 ℃ (being lower than LCST); can protect carrier long-term circulation in human body not to be eliminated; and under heat-therapeutic action; tumor heating part megadyne temperature degree is higher than 37 ℃; generally at 40 ℃; this moment, hydrophilic segment temperature-sensitive polymer structure just changed; become lyophobic dust and assemble at the tumor tissues position; have an effect with surrounding tissue; hydrophobic fragment is discharged at the tumor tissue cell place as the entrained chemotherapeutics of carrier, reach the purpose that targeting discharges medicine.When the antineoplastic nanometer heat sensitive target medicine carrier that the present invention prepares had solved existing chemotherapy combined with hyperthermia application of treatment tumor, chemotherapeutics had reduced the infringement of chemotherapeutics to human normal tissue cell in the tumor tissues not high defective that distributes.
Description of drawings
Figure---measure carrier particle diameter (nanoscale) figure under the different temperatures.
The specific embodiment
At first be the preparation of hydrophilic segment:
With monomer NIPAAm, Aam, initiator A IBN and chain-transferring agent 2 mercapto ethanol add in the reaction bulb by prescription, add ethanol again and make solvent, remove the oxygen in the reaction system, are warming up to 60-70 ℃, stirred for several hour under the nitrogen protection.Product is purification in the alcohol-ether system, dialyses in the rearmounted bag filter of vacuum drying, removes small-molecule substance.Lyophilization then gets poly (NIPAAm-co-Aam) copolymer, and its reaction equation is
Carry out the preparation of block copolymer then:
With poly (NIPAAm-co-Aam) copolymer and D, the L-lactide adds in the test tube according to a certain ratio, adds the stannous octoate xylene solution; Vacuum condition remove down anhydrate and the rearmounted 150 ℃ of oil baths of dimethylbenzene in react; After reaction finishes with product ethanol stripping, and with alcohol-ether system purification; Vacuum drying gets poly (NIPAAm-co-Aam) copolymer and poly-D, the block copolymer of L-lactide.Its reaction equation is
Block copolymer with some is dissolved among the DMAc again, and solution is positioned in the bag filter of molecular weight 12000, dialyses 24 hours for 4 ℃, and block copolymer is spontaneous formation micellar structure in water.Solution lyophilization in the bag filter is promptly got temperature sensitive carrier, 4 ℃ of preservations.
Hydrophilic segment length makes it be easy to spontaneous formation micelle in aqueous solution greater than hydrophobic fragment in the block copolymer, and its hydrophobic fragment is twined mutually and formed hydrophobicity " kernel ", outside hydrophilic segment then is looped around, forms flexible hydrophilic " shell ".Hydrophobic cores provides a stabile microenvironment as the carrier of chemotherapeutics for the hydrophobicity chemotherapeutics, and the hydrophilic shell can stably be present in aqueous solution or the body fluid micelle.
Its lower critical solution temperature LCST is higher than 37 ℃, is lower than after the thermotherapy 42 ℃ of tumor tissues temperature.
Under the physiological condition, pass through interaction of hydrogen bond between hydrone and the polymer, make polymer chain be extended configuration, high-hydrophilic, water soluble, and hydrophilic segment length is greater than hydrophobic fragment, so the hydrophilic shell that the temperature-sensitive polymer (polymer) of hydrophilic segment is constituted stably is present in aqueous solution or the body fluid micelle, the circulation for a long time and not removed by body in vivo of protection carrier; In case arrive the heating tumor tissues, temperature is higher than LCST, hydrogen bond breaks, active force between the polymer hydrophobic group is preponderated, the polymer chain shrinkage, and hydrone is extruded from polymer, polymer precipitation, become high hydrophobicity, water-fast material, promptly the structure of polymer changes, and becomes lyophobic dust and mutual aggregate and precipitate; Contained chemotherapeutics is able to discharge at the tumor tissues place, thereby reaches the purpose and the effect of treatment tumor, has avoided the infringement of chemotherapeutics to human normal tissue cell simultaneously.
The carrier particle size range helps in vivo long-term circulation and is not eliminated below 200 nanometers.
It is below 15000 that hydrophilic segment adopts molecular weight, is beneficial to human body and excretes by kidney.
What hydrophobic fragment adopted is the polylactic acid material, is Biodegradable material, after the hydrolysis to the human body avirulence.Other materials with identical or similar characteristics also can adopt.
Adopt the pharmaceutical carrier of the present invention's preparation can carry the chemotherapeutics of multiple treatment tumor, as paclitaxel, Docetaxel etc.
Experiment confirm:
The block copolymer amount and the LCST of the present invention's preparation
| Mw | Mn | Mw/Mn | LCST | |
| P oly( NIPAAM-co-Aam) P oly( NIPAAM-co-Aam)-b-PLA | 8100 14700 | 3300 4800 | 2.40 3.06 | 48.0 41.5 |
As shown in Figure 1, shown measurement carrier particle diameter (nanoscale) under the different temperatures.
Protection scope of the present invention is not limited in the description of the above-mentioned specific embodiment.
Claims (4)
1. the preparation method of antineoplastic nanometer heat sensitive target medicine carrier is characterized in that following steps:
(1) the segmental preparation of hydrophilic site:
With N-N-isopropylacrylamide (NIPAAm) and acrylamide (Aam) is monomer polymerization, by free radicals copolymerization reaction, forms copolymer poly (NIPAAm-co-Aam), and its reaction equation is
(2) preparation of block copolymer:
With copolymer poly (NIPAAm-co-Aam) and D, the L-lactide passes through to get poly (NIPAAm-co-Aam) copolymer and poly-D behind the ring-opening polymerization, the block copolymer of L-lactide, and its reaction equation is
(3) preparation of carrier:
The block copolymer of some is dissolved among the DMAc, and solution is positioned in the bag filter of molecular weight 12000, dialyses 24 hours for 4 ℃, and block copolymer is spontaneous formation micellar structure in water, and solution lyophilization in the bag filter is promptly got carrier, 4 ℃ of preservations.
2. the preparation method of antineoplastic nanometer heat sensitive target medicine carrier according to claim 1; the concrete steps that it is characterized in that step (1) hydrophilic site produced in fragments are with monomer NIPAAm, Aam; initiator A IBN and chain-transferring agent 2 mercapto ethanol add in the reaction bulb; add ethanol and make solvent; remove the oxygen in the reaction system; be warming up to 60-70 ℃, stirred for several hour under the nitrogen protection.Product is purification in the alcohol-ether system, dialyses in the rearmounted bag filter of vacuum drying, removes small-molecule substance.Lyophilization then gets poly (NIPAAm-co-Aam) copolymer.
3. the preparation method of antineoplastic nanometer heat sensitive target medicine carrier according to claim 1, the concrete steps that it is characterized in that the preparation of step (2) block copolymer are with copolymer poly (NIPAAm-co-Aam) and D, L-third hands over fat to add in the test tube in proportion, add the stannous octoate xylene solution, vacuum condition remove down anhydrate and dimethylbenzene after, put in 150 ℃ of oil baths and react, after reaction finishes with product ethanol stripping, and with alcohol-ether system purification, vacuum drying gets poly (NIPAAm-Aam) copolymer and poly-D, the block copolymer of L-lactide.
4. the preparation method of antineoplastic nanometer heat sensitive target medicine carrier according to claim 3 is characterized in that the hydrophilic segment molecular weight is greater than hydrophobic fragment in the block copolymer.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100405719A CN1329081C (en) | 2005-06-17 | 2005-06-17 | Method for preparing antineoplastic nanometer heat sensitive target medicine carrier |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100405719A CN1329081C (en) | 2005-06-17 | 2005-06-17 | Method for preparing antineoplastic nanometer heat sensitive target medicine carrier |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1720997A true CN1720997A (en) | 2006-01-18 |
| CN1329081C CN1329081C (en) | 2007-08-01 |
Family
ID=35911831
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005100405719A Expired - Fee Related CN1329081C (en) | 2005-06-17 | 2005-06-17 | Method for preparing antineoplastic nanometer heat sensitive target medicine carrier |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1329081C (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101045066B (en) * | 2006-03-31 | 2010-05-12 | 国家纳米科学中心 | Temperature sensing matter used for preparing medicine to inhibiting tumor angiogenesis, and its use |
| CN106334190A (en) * | 2016-08-25 | 2017-01-18 | 北京科技大学 | Compound drug carrier for multi-response mechanism and preparation method thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1186377C (en) * | 2003-05-15 | 2005-01-26 | 复旦大学 | Multifunctional organic-inorganic composite polymeric microball and preparing method thereof |
| CN1537636A (en) * | 2003-10-13 | 2004-10-20 | 四川大学华西药学院 | High-molecular mPEG-PLGA-mPEG accessory medicine for medicine use, prepu. method and application thereof |
-
2005
- 2005-06-17 CN CNB2005100405719A patent/CN1329081C/en not_active Expired - Fee Related
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101045066B (en) * | 2006-03-31 | 2010-05-12 | 国家纳米科学中心 | Temperature sensing matter used for preparing medicine to inhibiting tumor angiogenesis, and its use |
| CN106334190A (en) * | 2016-08-25 | 2017-01-18 | 北京科技大学 | Compound drug carrier for multi-response mechanism and preparation method thereof |
| CN106334190B (en) * | 2016-08-25 | 2019-09-24 | 北京科技大学 | A kind of multiple response mechanism compound pharmaceutical carrier and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1329081C (en) | 2007-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Mazidi et al. | Smart stimuli-responsive implantable drug delivery systems for programmed and on-demand cancer treatment: An overview on the emerging materials | |
| Hua et al. | Hypoxia-responsive lipid-poly-(hypoxic radiosensitized polyprodrug) nanoparticles for glioma chemo-and radiotherapy | |
| Xu et al. | Multifunctional silica nanoparticles as a promising theranostic platform for biomedical applications | |
| Ding et al. | NO-releasing polypeptide nanocomposites reverse cancer multidrug resistance via triple therapies | |
| Xu et al. | pH/ROS dual-sensitive and chondroitin sulfate wrapped poly (β-amino ester)-SA-PAPE copolymer nanoparticles for macrophage-targeted oral therapy for ulcerative colitis | |
| Bajaj et al. | Hyaluronic acid-based hydrogel for regional delivery of paclitaxel to intraperitoneal tumors | |
| Cheng et al. | Hierarchically self-assembled supramolecular host–guest delivery system for drug resistant cancer therapy | |
| Kim et al. | Flt1 peptide–hyaluronate conjugate micelle-like nanoparticles encapsulating genistein for the treatment of ocular neovascularization | |
| CN103656652B (en) | A kind of sensitive response type polymer nano-micelle and its preparation method and application | |
| Laroui et al. | Gastrointestinal delivery of anti-inflammatory nanoparticles | |
| Sonker et al. | Review of recent advances and their improvement in the effectiveness of hydrogel-based targeted drug delivery: a hope for treating cancer | |
| CN105963706B (en) | A kind of branching HPMA copolymer-DOX conjugate and its preparation method and application | |
| CN107375935B (en) | Temperature-sensitive hydrogel nano-drug delivery system | |
| CN101480377B (en) | Method for preparing tumor enzyme-targeted nano medicine-carrying polymer microsphere | |
| CN115120738B (en) | Imiquimod prodrug nano-particles, and preparation method and application thereof | |
| Guo et al. | Dual functional matrix metalloproteinase-responsive curcumin-loaded nanoparticles for tumor-targeted treatment | |
| CN1301748C (en) | Antineoplastic nanometer heat sensitive target medicine carrier used combined with chemical therapy and heat therapy | |
| Peng et al. | Gout therapeutics and drug delivery | |
| Yu et al. | Effects of different conformations of polylysine on the anti-tumor efficacy of methotrexate nanoparticles | |
| Wu et al. | The Smart Dual-Stimuli Responsive Nanoparticles for Controlled Anti-Tumor Drug Release and Cancer Therapy | |
| CN108794709A (en) | A kind of amphiphilic star-like block polymer preparation method of superelevation pH stimuli responsives | |
| KR101586866B1 (en) | pH sensitive nano particle for drug delivery and preparation method thereof | |
| Chen et al. | Polymeric nanomaterial strategies to encapsulate and deliver biological drugs: points to consider between methods | |
| Hua et al. | Reactive oxygen species and nitric oxide scavenging nanoparticles alleviating rheumatoid arthritis through adjusting the seeds and growing soils | |
| Ullah et al. | Nanogels: Update on the methods of synthesis and applications for cardiovascular and neurological complications |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070801 Termination date: 20100617 |